Apellis Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Apellis Pharmaceuticals (Nasdaq: APLS) has announced its upcoming presentation at the 43rd Annual J.P.

Rhea-AI Summary

Apellis Pharmaceuticals (Nasdaq: APLS) has announced its upcoming presentation at the 43rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for Monday, January 13, 2025, at 9:45 a.m. PT.

The company will provide a live webcast of the conference presentation, which will be accessible through the 'Events and Presentations' page in the 'Investors and Media' section of Apellis' website. For those unable to attend live, a replay of the webcast will remain available for approximately 90 days after the event.

Argus Session date unavailable

+2.75% session move Open Argus

Details

News Market Reaction – APLS

The recorded move for APLS in the trading session of this news was +2.75%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WALTHAM, Mass., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at the 43^rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025, at 9:45 a.m. PT.

The live conference webcast will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcast will be available for approximately 90 days following the event.

About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two approved medicines targeting C3. These include the first-ever therapy for geographic atrophy, a leading cause of blindness around the world. We believe we have only begun to unlock the potential of targeting C3 across serious retinal, rare, and neurological diseases. For more information, please visit http://apellis.com or follow us on Twitter and LinkedIn.

Investor Contact: 
Meredith Kaya 
meredith.kaya@apellis.com
617.599.8178

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Apellis Pharmaceuticals (APLS) presenting at the J.P. Morgan Healthcare Conference 2025?

Apellis Pharmaceuticals is presenting on Monday, January 13, 2025, at 9:45 a.m. PT at the 43rd Annual J.P. Morgan Healthcare Conference.

How can investors watch Apellis' (APLS) J.P. Morgan Healthcare Conference presentation?

Investors can watch the live webcast through the 'Events and Presentations' page in the 'Investors and Media' section of Apellis' website.

How long will the replay of Apellis' (APLS) J.P. Morgan presentation be available?

The replay of the webcast will be available for approximately 90 days following the event.

Where can I find Apellis' (APLS) J.P. Morgan Conference presentation materials?

The presentation materials can be accessed through the 'Events and Presentations' page in the 'Investors and Media' section of Apellis' website.